Clinical Trial Update: Safety Study of Crushed Deferasirox Film Coated Tablets in Pediatric Patients With Transfusional Hemosiderosis [Phase 4]

View source ↗

Summary

Phase 4 safety study of crushed deferasirox film-coated tablets in pediatric patients with transfusional iron overload completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Overload
• Transfusional Iron Overload

Drugs mentioned

• Deferasirox film-coated tablets (crushed) (deferasirox)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Iron Overload | Phase 4 | Status: COMPLETED | Results posted: 2020-08-03